Literature DB >> 9272937

Pleural diseases related to metastatic malignancies.

S A Sahn.   

Abstract

Pleural effusions associated with malignancy (either malignant or paramalignant) pose diagnostic and therapeutic dilemmas for the clinician. This article reviews the common causes of malignant and paramalignant pleural effusions, pathogenesis, clinical presentation, chest radiography, pleural fluid characteristics, diagnosis, prognosis, and treatment. Talc, used either by poudrage or slurry, is the most effective agent used for pleurodesis. Talc, which needs to be sterilized, has no clinically important immediate, short-term or long-term adverse effects.

Entities:  

Mesh:

Year:  1997        PMID: 9272937     DOI: 10.1183/09031936.97.10081907

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  29 in total

1.  BTS guidelines for the management of malignant pleural effusions.

Authors:  G Antunes; E Neville; J Duffy; N Ali
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

Review 2.  Switching off malignant pleural effusion formation-fantasy or future?

Authors:  Magda Spella; Anastasios D Giannou; Georgios T Stathopoulos
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

3.  In-depth proteomic analysis of six types of exudative pleural effusions for nonsmall cell lung cancer biomarker discovery.

Authors:  Pei-Jun Liu; Chi-De Chen; Chih-Liang Wang; Yi-Cheng Wu; Chia-Wei Hsu; Chien-Wei Lee; Lien-Hung Huang; Jau-Song Yu; Yu-Sun Chang; Chih-Ching Wu; Chia-Jung Yu
Journal:  Mol Cell Proteomics       Date:  2015-01-31       Impact factor: 5.911

4.  Anaplastic thyroid carcinoma presenting as bilateral pleural effusion.

Authors:  R Sodhi; G Sindhwani; S Chandra; D Anand
Journal:  Lung India       Date:  2014-07

5.  Prolonged pleural catheters in the management of pleural effusions due to breast cancer.

Authors:  Ozkan Demirhan; Cetin Ordu; Alper Toker
Journal:  J Thorac Dis       Date:  2014-02       Impact factor: 2.895

6.  Role of blind closed pleural biopsy in the managment of pleural exudates.

Authors:  Marco F Pereyra; Esther San-José; Lucía Ferreiro; Antonio Golpe; José Antúnez; Francisco-Javier González-Barcala; Ihab Abdulkader; José M Álvarez-Dobaño; Nuria Rodríguez-Núñez; Luis Valdés
Journal:  Can Respir J       Date:  2013-08-15       Impact factor: 2.409

7.  Pleural effusion detected at CT prior to primary cytoreduction for stage III or IV ovarian carcinoma: effect on survival.

Authors:  Oleg Mironov; Nicole M Ishill; Svetlana Mironov; Hebert Alberto Vargas; Junting Zheng; Chaya S Moskowitz; Yukio Sonoda; Ralph S Papas; Dennis S Chi; Hedvig Hricak
Journal:  Radiology       Date:  2010-12-30       Impact factor: 11.105

8.  Long-term outcome of pleurodesis with OK-432 in metastatic breast cancer: a new risk model for success from an analysis of 75 cases.

Authors:  Nobuaki Matsubara; Kuniaki Itoh; Hirofumi Mukai; Shunji Nagai
Journal:  Int J Clin Oncol       Date:  2011-10-07       Impact factor: 3.402

Review 9.  [Radiological diagnostics of Hodgkin- and non-Hodgkin lymphomas of the thorax].

Authors:  M Uffmann; C Schaefer-Prokop
Journal:  Radiologe       Date:  2004-05       Impact factor: 0.635

Review 10.  Interventional pulmonologist perspective: treatment of malignant pleural effusion.

Authors:  Andrew J Sweatt; Arthur Sung
Journal:  Curr Treat Options Oncol       Date:  2014-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.